Hypertriglyceridemia (HTG) is postulated to be a rare cause of acute pancreatitis accounting for approximately 4% of causes. A serum triglyceride (TG) level above 1,000 mg/dl in the setting of pancreatitis and absent of other major causes is necessary to describe hypertriglyceridemia as a cause of acute pancreatitis. The mechanism involves the degradation of triglycerides by pancreatic lipase to release free fatty acids that induces free radical damage to the tissues. The major cornerstone in management is by reducing the triglyce ride level to below 1000 mg/dL to achieve both the subsidial of the ongoing attack and the effective prevention of further episodes of pancreatitis. This can be achieved by a spectrum of treatment modalities ranging from dietary restriction of fat, administration of lipid-lowering agents to experiences with plasmapheresis and effective lipid pharesis however, the latter modality haven't been sufficiently discussed regarding therapeutic effects. This case reports a young female, 22 years old female patient who is non alcoholic, non diabetic, non obese with negative history for gall stones or significant drug use, diagnosed with hypertriglyceridemic acute pancreatitis associated with acute kidney injury, and received one session of hemodialysis then plasmapharesis was initiated and she received 8 sessions with full dose of hypolipidemics, and responded only to plasmapharesis.
___
Zhang K, Cox K, Sellers Z. Plasmapheresis for Hypertriglyceridemia-Induced Acute Pancreatitis in a Child: A Case Report and Brief Review of the Literature. Pancreas 2017; 58-59.
Näsström B, Olivecrona G, Olivecrona T, et al. Lipoprotein lipase during continuous heparin infusion: tissue stores become partially depleted. J Lab Clin Med 2001; 138: 206-213.
Dominguez-Munoz J. Malfertheiner P, Ditschhneit H, et al. Hyperlipidemia in acute pancreatitis. Relationship with etiology, onset and severity of the disease.Int J Pancreatol 1991; 10: 261-267.
Nawaz H, Koutroumpakis E, Easler J. et al. Elevated serum triglycerides are independently associated with persistent organ failure in acute pancreatitis. Am J Gastroenterol 2015; 110: 1497-1503.
Valdivielso P, Ramírez-Bueno A, Ewald N. Current knowledge of hypertriglyceridemic pancreatitis. Eur J Intern Med 2014; 25: 689- 694.
Havel R. Pathogenesis, differentiation and management of hypertriglyceridemia. Adv Intern Med 1969; 15: 117-154.
Click B, Ketchum A, Turner R, et al. The role of apheresis in hypertriglyceridemia-induced acute pancreatitis: a systematic review. Pancreatology 2015; 15: 313-320.
Lennertz A, Parhofer K, Samtleben W, Bosch T. Therapeutic plasma exchange in patients with chylomicronemia syndrome. complicated by acute pancreatitis therapeutic Apheresis 1999; 227-233.
Fortson M, Freedman S, Webster P. Clinical assessment of hyperlipidemic pancreatitis. Am J Gastroenterol 1995; 90: 2134-2139.
Yadav D, Pitchumoni C. Issues in hyperlipedimic pancreatitis.j ClinGastroeneterol 2003; 36: 753-758.
Tsuang W, Navaneethan U, Ruiz L, Palascak J, Gelrud A. Hypertriglyceridemic Pancreatitis: Presentation and Management. The American Journal of Gastroenterology 2009: 984-991.